Lazard Asset Management LLC Bluebird Bio, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of Lazard Asset Management LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 358 shares of BLUE stock, worth $3,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares
358
Previous 5,332 93.29%
Holding current value
$3,211
Previous $5,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.47 - $1.35 $2,337 - $6,714
-4,974 Reduced 93.29%
358 $0
Q2 2024

Aug 14, 2024
SELL
$0.85 - $1.26 $8,369 - $12,405
-9,846 Reduced 64.87%
5,332 $5,000
Q1 2024

May 14, 2024
BUY
$0.91 - $1.75 $7,573 - $14,565
8,323 Added 121.42%
15,178 $19,000
Q4 2023

Feb 14, 2024
SELL
$1.32 - $4.83 $531 - $1,946
-403 Reduced 5.55%
6,855 $9,000
Q3 2023

Nov 14, 2023
BUY
$3.02 - $4.05 $993 - $1,332
329 Added 4.75%
7,258 $22,000
Q2 2023

Aug 14, 2023
BUY
$2.79 - $5.03 $641 - $1,156
230 Added 3.43%
6,929 $22,000
Q1 2023

May 15, 2023
BUY
$3.14 - $8.22 $12,095 - $31,663
3,852 Added 135.3%
6,699 $20,000
Q4 2022

Feb 14, 2023
SELL
$5.77 - $8.49 $4,598 - $6,766
-797 Reduced 21.87%
2,847 $19,000
Q3 2022

Nov 14, 2022
BUY
$3.75 - $7.39 $116 - $229
31 Added 0.86%
3,644 $22,000
Q2 2022

Aug 09, 2022
BUY
$2.94 - $5.23 $402 - $716
137 Added 3.94%
3,613 $14,000
Q1 2022

May 13, 2022
SELL
$4.07 - $10.6 $23,308 - $60,706
-5,727 Reduced 62.23%
3,476 $16,000
Q4 2021

Feb 09, 2022
BUY
$8.96 - $16.31 $63,929 - $116,371
7,135 Added 345.02%
9,203 $91,000
Q3 2021

Nov 15, 2021
SELL
$11.24 - $21.0 $11,329 - $21,168
-1,008 Reduced 32.77%
2,068 $39,000
Q2 2021

Aug 12, 2021
BUY
$18.04 - $22.09 $54,372 - $66,579
3,014 Added 4861.29%
3,076 $97,000
Q4 2020

Feb 11, 2021
SELL
$27.5 - $37.92 $1,320 - $1,820
-48 Reduced 43.64%
62 $2,000
Q3 2020

Nov 13, 2020
SELL
$34.44 - $43.75 $42,981 - $54,600
-1,248 Reduced 91.9%
110 $5,000
Q2 2020

Aug 13, 2020
BUY
$27.12 - $45.97 $36,828 - $62,427
1,358 New
1,358 $82,000
Q4 2019

Feb 13, 2020
SELL
$46.96 - $61.67 $1,080 - $1,418
-23 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$59.47 - $93.1 $39,071 - $61,166
-657 Reduced 96.62%
23 $2,000
Q3 2015

Jul 15, 2019
BUY
N/A
100 Added 17.24%
680 $58,000
Q2 2015

Jul 08, 2019
SELL
N/A
-4,194 Reduced 87.85%
580 $97,000
Q4 2014

Aug 29, 2019
BUY
N/A
4,774
4,774 $437,000

Others Institutions Holding BLUE

# of Institutions
151
Shares Held
63.4M
Call Options Held
264K
Put Options Held
428K
View Full List

About bluebird bio, Inc.

BLUE Quotes by TradingView
  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $692M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email